145 related articles for article (PubMed ID: 4024860)
1. Enteric-coated acetylsalicylic acid plus dipyridamole compared with anticoagulants in the prevention of ischemic events in patients with transient ischemic attacks.
Eriksson SE
Acta Neurol Scand; 1985 Jun; 71(6):485-93. PubMed ID: 4024860
[TBL] [Abstract][Full Text] [Related]
2. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
3. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
Diener HC; Cunha L; Forbes C; Sivenius J; Smets P; Lowenthal A
J Neurol Sci; 1996 Nov; 143(1-2):1-13. PubMed ID: 8981292
[TBL] [Abstract][Full Text] [Related]
4. Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
Takahashi S; Mizuno O; Sakaguchi T; Yamada T; Inuyama L
Adv Ther; 2014 Jan; 31(1):118-29. PubMed ID: 24385407
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet therapy is effective in the prevention of stroke or death in women: subgroup analysis of the European Stroke Prevention Study (ESPS).
Sivenius J; Riekkinen PJ; Kilpeläinen H; Laakso M; Penttilä I
Acta Neurol Scand; 1991 Oct; 84(4):286-90. PubMed ID: 1772001
[TBL] [Abstract][Full Text] [Related]
6. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
Rouhl RP; Lodder J
Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236
[TBL] [Abstract][Full Text] [Related]
7. Randomised trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischaemic attacks.
Herskovits E; Vazquez A; Famulari A; Smud R; Tamaroff L; Fraiman H; Gonzalez AM; Vila J; Matera V
Lancet; 1981 May; 1(8227):966-8. PubMed ID: 6112386
[TBL] [Abstract][Full Text] [Related]
8. The European Stroke Prevention Study (ESPS): results by arterial distribution.
Sivenius J; Riekkinen PJ; Smets P; Laakso M; Lowenthal A
Ann Neurol; 1991 Jun; 29(6):596-600. PubMed ID: 1892362
[TBL] [Abstract][Full Text] [Related]
9. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
Luijckx GJ; De Keyser JH
Ned Tijdschr Geneeskd; 2006 Aug; 150(33):1812-4. PubMed ID: 16967590
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
Saxena R; Koudstaal P
Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
Koudstaal PJ
Cochrane Database Syst Rev; 2000; (2):CD000187. PubMed ID: 10796315
[TBL] [Abstract][Full Text] [Related]
12. Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group.
Sivenius J; Cunha L; Diener HC; Forbes C; Laakso M; Lowenthal A; Smets P; Riekkinen P
Acta Neurol Scand; 1999 Jan; 99(1):54-60. PubMed ID: 9925239
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
14. Short-term outcome of medically treated patients with transient ischemic attacks, reversible ischemic neurologic deficits and strokes with minimum residuum.
Calandre L; Molina JA
Eur Neurol; 1985; 24(4):281-5. PubMed ID: 2408892
[TBL] [Abstract][Full Text] [Related]
15. Treatment program and comparison between anticoagulants and platelet aggregation inhibitors after transient ischemic attack.
Burén A; Ygge J
Stroke; 1981; 12(5):578-80. PubMed ID: 7303042
[TBL] [Abstract][Full Text] [Related]
16. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.
Dengler R; Diener HC; Schwartz A; Grond M; Schumacher H; Machnig T; Eschenfelder CC; Leonard J; Weissenborn K; Kastrup A; Haberl R;
Lancet Neurol; 2010 Feb; 9(2):159-66. PubMed ID: 20060783
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of vascular complications after cerebral ischemia of arterial origin. European Stroke and Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT): moderated coagulation, aspirin-dipyridamole combination or aspirin alone?].
De Schryver EL; Gorter JW; Algra A; van Gijn J
Rev Med Interne; 1999 May; 20(5):397-9. PubMed ID: 10365408
[No Abstract] [Full Text] [Related]
18. An investigation of the effect on platelet function of acetylsalicylic acid, dipyridamole and the two drugs in combination in patients with transient attacks of ischaemia.
Fassio G; Albizzati MG; Bassi S; Frattola L
J Int Med Res; 1979; 7(6):492-501. PubMed ID: 391623
[TBL] [Abstract][Full Text] [Related]
19. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].
Brechter C; Bäcklund H; Krook H; Müller R; Nitelius E; Olsson JE; Olsson O; Thornberg A
Lakartidningen; 1980 Dec; 77(52):4947-56. PubMed ID: 7010029
[No Abstract] [Full Text] [Related]
20. Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. ESPS Investigators. European Stroke Prevention Study.
Forbes CD
Thromb Res; 1998 Sep; 92(1 Suppl 1):S1-6. PubMed ID: 9781830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
